company background image
AOXG logo

Aoxing Pharmaceutical Company OTCPK:AOXG Stock Report

Last Price

US$0.0049

Market Cap

US$373.4k

7D

4.3%

1Y

390.0%

Updated

20 Mar, 2024

Data

Company Financials

Aoxing Pharmaceutical Company, Inc.

OTCPK:AOXG Stock Report

Market Cap: US$373.4k

AOXG Stock Overview

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.

AOXG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Aoxing Pharmaceutical Company, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aoxing Pharmaceutical Company
Historical stock prices
Current Share PriceUS$0.0049
52 Week HighUS$0.014
52 Week LowUS$0.001
Beta0
1 Month Change-23.44%
3 Month Change6.52%
1 Year Change390.00%
3 Year Change-70.12%
5 Year Change-81.15%
Change since IPO-99.97%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

AOXGUS PharmaceuticalsUS Market
7D4.3%-0.007%1.0%
1Y390.0%25.3%31.2%

Return vs Industry: AOXG exceeded the US Pharmaceuticals industry which returned 23.4% over the past year.

Return vs Market: AOXG exceeded the US Market which returned 27.7% over the past year.

Price Volatility

Is AOXG's price volatile compared to industry and market?
AOXG volatility
AOXG Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: AOXG's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine AOXG's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aZhenjiang Yuehttps://axzyen.icm.cn

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China. The company’s principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain.

Aoxing Pharmaceutical Company, Inc. Fundamentals Summary

How do Aoxing Pharmaceutical Company's earnings and revenue compare to its market cap?
AOXG fundamental statistics
Market capUS$373.43k
Earnings (TTM)-US$1.46m
Revenue (TTM)US$30.11m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AOXG income statement (TTM)
RevenueUS$30.11m
Cost of RevenueUS$7.17m
Gross ProfitUS$22.94m
Other ExpensesUS$24.40m
Earnings-US$1.46m

Last Reported Earnings

Mar 31, 2017

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did AOXG perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.